Anaerobic Feces Processing for Fecal Microbiota Transplantation Improves Viability of Obligate Anaerobes
- PMID: 37764082
- PMCID: PMC10535047
- DOI: 10.3390/microorganisms11092238
Anaerobic Feces Processing for Fecal Microbiota Transplantation Improves Viability of Obligate Anaerobes
Abstract
Fecal microbiota transplantation (FMT) is under investigation for several indications, including ulcerative colitis (UC). The clinical success of FMT depends partly on the engraftment of viable bacteria. Because the vast majority of human gut microbiota consists of anaerobes, the currently used aerobic processing protocols of donor stool may diminish the bacterial viability of transplanted material. This study assessed the effect of four processing techniques for donor stool (i.e., anaerobic and aerobic, both direct processing and after temporary cool storage) on bacterial viability. By combining anaerobic culturing on customized media for anaerobes with 16S rRNA sequencing, we could successfully culture and identify the majority of the bacteria present in raw fecal suspensions. We show that direct anaerobic processing of donor stool is superior to aerobic processing conditions for preserving the bacterial viability of obligate anaerobes and butyrate-producing bacteria related to the clinical response to FMT in ulcerative colitis patients, including Faecalibacterium, Eubacterium hallii, and Blautia. The effect of oxygen exposure during stool processing decreased when the samples were stored long-term. Our results confirm the importance of sample conditioning to preserve the bacterial viability of oxygen-sensitive gut bacteria. Anaerobic processing of donor stool may lead to increased clinical success of FMT, which should further be investigated in clinical trials.
Keywords: anaerobic bacteria; bacterial viability; culturability; culturing of fecal microbiota; fecal microbiota transplantation; frozen microbiota; gut microbiota; next-generation sequencing; sample processing; ulcerative colitis.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analysis, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures




References
-
- Quraishi M.N., Widlak M., Bhala N., Moore D., Price M., Sharma N., Iqbal T.H. Systematic review with meta-analysis: The efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection. Aliment. Pharmacol. Ther. 2017;46:479–493. doi: 10.1111/apt.14201. - DOI - PubMed
-
- Ramai D., Zakhia K., Fields P.J., Ofosu A., Patel G., Shahnazarian V., Lai J.K., Dhaliwal A., Reddy M., Chang S. Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis. Dig. Dis. Sci. 2021;66:369–380. doi: 10.1007/s10620-020-06185-7. - DOI - PubMed
-
- Lee C.H., Steiner T., Petrof E.O., Smieja M., Roscoe D., Nematallah A., Weese J.S., Collins S., Moayyedi P., Crowther M. Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial. JAMA. 2016;315:142–149. doi: 10.1001/jama.2015.18098. - DOI - PubMed
-
- Vaughn B.P., Fischer M., Kelly C.R., Allegretti J.R., Graiziger C., Thomas J., McClure E., Kabage A.J., Khoruts A. Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection. Clin. Gastroenterol. Hepatol. 2022;21:1330–1337.e2. doi: 10.1016/j.cgh.2022.09.008. - DOI - PubMed
-
- Moayyedi P., Surette M.G., Kim P.T., Libertucci J., Wolfe M., Onischi C., Armstrong D., Marshall J.K., Kassam Z., Reinisch W., et al. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology. 2015;149:102–109.e6. doi: 10.1053/j.gastro.2015.04.001. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources